As a result of these limitations, several molecular diagnoses have been proposed to subclassify NSCLC in recent years, such as EGFR mutations, K-ras mutations, EML4–ALK fusions and miRNA profiling [11], [39]–[42]. Here, KRAS is linked to non-small cell lung carcinoma.